Method for treatment of dyslipidemia in humans
AssigneeSchering Corporation
InventorWilliam Darrow
Life of this patent
Estimating the term…
Abstract
A method for treating dyslipidemia in a human is disclosed, the dyslipidemia is characterized by an HDL serum cholesterol level of below about 50 milligrams per deciliter. The method consists of the administration to said human of a therapeutically effective amount of 5-{(R)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropy)amino]-ethyl}salicylamide, 5-{(S)-1-hydroxy-2-[(R)-(1-methyl-3- phenylpropyl)amino]ethyl}salicylamide or a pharmaceutically acceptable salt thereof or a mixture thereof.
Claims10
A method for treating dyslipidemia in humans by administering a therapeutically effective amount of 5-{(S)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropyl)amino]-ethyl}salicylamide , 5-{(R)-1-hydroxy-2-[(R)-(1-methyl-3-phenylpropyl)amino]ethyl}salicylamide or a pharmaceutically acceptable salt thereof as well as a mixture thereof to a human in need thereof.
Dependencies are inferred from the claim text.